Office of Program Operations

Kelly A. Shipkowski, Ph.D., D.A.B.T.
Kelly A. Shipkowski, Ph.D., D.A.B.T.
Staff Scientist;
Health Science Evaluator
Tel 240-987-8115
[email protected]
530 Davis Dr
530 Davis Drive (Keystone Bldg)
Durham, NC 27713

Much of the work carried out by DTT is in support of the National Toxicology Program (NTP), an interagency partnership of the Food and Drug Administration, National Institute for Occupational Safety and Health, and NIEHS.

Visit the NTP Website

Kelly A. Shipkowski, Ph.D., D.A.B.T., is a Health Science Evaluator in the Office of Program Operations in the Division of Translational Toxicology (DTT). Shipkowski is training to be a Contract Officer’s Representative to assist with the administration and monitoring of contracts for NTP scientific literature evaluations and toxicology and carcinogenicity studies. She also supports the design, conduct, interpretation, and reporting of studies evaluating the toxicity and carcinogenicity of chemicals of human health concern. Additionally, she serves as a project leader for NTP studies of metals and other potentially hazardous environmental exposures.

Prior to joining DTT, Shipkowski worked as a Lead Toxicologist at ICF, a global consulting firm. She served as the technical lead for ICF’s development of technical and toxicity reports for NTP, while also providing toxicology support for systematic review projects assessing the human health effects of chemicals of concern.

Shipkowski received a B.S. in both biology and chemistry from Methodist University in 2010 and a Ph.D. in toxicology from North Carolina State University in 2015. Following completion of her Ph.D. she worked as an intramural research training award (IRTA) postdoctoral fellow at DTT.

Selected Publications

  1. Shipkowski KA, Sanders JM, McDonald JD, Garner CE, Doyle-Eisele M, Wegerski CJ, Waidyanatha S. (2019). Comparative disposition of dimethylaminoethanol and choline in rats and mice following oral or intravenous administration. Toxicol Appl Pharmacol. 378:114592 [Abstract Shipkowski KA, Sanders JM, McDonald JD, Garner CE, Doyle-Eisele M, Wegerski CJ, Waidyanatha S. (2019). Comparative disposition of dimethylaminoethanol and choline in rats and mice following oral or intravenous administration. Toxicol Appl Pharmacol. 378:114592]
  2. Shipkowski KA, Sanders JM, McDonald JD, Walker NJ, Waidyanatha, S. (2019). Disposition of fullerene C60 in rats following intratracheal or intravenous administration. Xenobiotica. 49(9): 1078-1085. [Abstract Shipkowski KA, Sanders JM, McDonald JD, Walker NJ, Waidyanatha, S. (2019). Disposition of fullerene C60 in rats following intratracheal or intravenous administration. Xenobiotica. 49(9): 1078-1085.]
  3. Shipkowski KA, Betz JM, Birnbaum LS, Bucher JR, Coates PM, Hopp C, MacKay D, Oketch-Rabah H, Walker NJ, Welch C, Rider CV. (2018). Naturally complex: Perspectives and challenges associated with botanical dietary supplement safety assessment. Food Chem Toxicol. 118: 963-971. [Abstract Shipkowski KA, Betz JM, Birnbaum LS, Bucher JR, Coates PM, Hopp C, MacKay D, Oketch-Rabah H, Walker NJ, Welch C, Rider CV. (2018). Naturally complex: Perspectives and challenges associated with botanical dietary supplement safety assessment. Food Chem Toxicol. 118: 963-971.]
  4. Shipkowski KA, Sheth CM, Smith MJ, Hooth MJ, White KL Jr, Germolec DR. (2017). Assessment of immunotoxicity in female Fischer 344/N and Sprague Dawley rats and female B6C3F1 mice exposed to hexavalent chromium via the drinking water. J Immunotoxicol. 14(1): 215-227. [Abstract Shipkowski KA, Sheth CM, Smith MJ, Hooth MJ, White KL Jr, Germolec DR. (2017). Assessment of immunotoxicity in female Fischer 344/N and Sprague Dawley rats and female B6C3F1 mice exposed to hexavalent chromium via the drinking water. J Immunotoxicol. 14(1): 215-227.]
  5. Germolec D, Luebke R, Rooney A, Shipkowski K, Vandebriel R, van Loveren H. (2017). Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment. Curr Opin Toxicol. 5: 55-59. [Abstract Germolec D, Luebke R, Rooney A, Shipkowski K, Vandebriel R, van Loveren H. (2017). Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment. Curr Opin Toxicol. 5: 55-59.]
  6. Sayers BC, Germolec DR, Walker NJ, Shipkowski KA, Stout MD, Cesta MF, Roycroft JH, White KL Jr, Baker GL, Dill JA, Smith MJ. (2016). Respiratory toxicity and immunotoxicity evaluations of microparticle and nanoparticle C60 fullerene aggregates in mice and rats following nose-only inhalation for 13 weeks. Nanotoxicology. 10(10): 1458-1468. [Abstract Sayers BC, Germolec DR, Walker NJ, Shipkowski KA, Stout MD, Cesta MF, Roycroft JH, White KL Jr, Baker GL, Dill JA, Smith MJ. (2016). Respiratory toxicity and immunotoxicity evaluations of microparticle and nanoparticle C60 fullerene aggregates in mice and rats following nose-only inhalation for 13 weeks. Nanotoxicology. 10(10): 1458-1468.]
  7. Shipkowski KA, Taylor AJ, Thompson EA, Glista-Baker EE, Sayers BC, Messenger ZJ, Bauer RN, Jaspers I, Bonner JC. (2015). An allergic lung microenvironment suppresses carbon nanotube-induced inflammasome activation via STAT6-dependent inhibition of caspase-1. PLoS One. 10(6): e0128888. [Abstract Shipkowski KA, Taylor AJ, Thompson EA, Glista-Baker EE, Sayers BC, Messenger ZJ, Bauer RN, Jaspers I, Bonner JC. (2015). An allergic lung microenvironment suppresses carbon nanotube-induced inflammasome activation via STAT6-dependent inhibition of caspase-1. PLoS One. 10(6): e0128888.]
  8. Taylor AJ, McClure CD, Shipkowski KA, Thompson EA, Hussain S, Garantziotis S, Parsons GN, Bonner JC. (2014). Atomic layer deposition coating of carbon nanotubes with aluminum oxide alters pro-fibrogenic cytokine expression by human mononuclear phagocytes in vitro and reduces lung fibrosis in mice in vivo. PLoS One. 2014. 9(9): e106870. [Abstract Taylor AJ, McClure CD, Shipkowski KA, Thompson EA, Hussain S, Garantziotis S, Parsons GN, Bonner JC. (2014). Atomic layer deposition coating of carbon nanotubes with aluminum oxide alters pro-fibrogenic cytokine expression by human mononuclear phagocytes in vitro and reduces lung fibrosis in mice in vivo. PLoS One. 2014. 9(9): e106870.]